Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Feb;4(1):i-ii.

Drugs for Parkinson’s disease: levodopa is still the gold standard

Roger M Pinder  1
Affiliations
Editorial

Drugs for Parkinson’s disease: levodopa is still the gold standard

Roger M Pinder. Neuropsychiatr Dis Treat. 2008 Feb.
No abstract available

PubMed Disclaimer

References

    1. Antonini A, Abbruzzese G, Barone P, et al. COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features. Neuropsychiatr Dis Treat. 2008;4:1–9. - PMC - PubMed
    1. Birkmayer W, Horneykiewicz O. The effect of 3,4-dihydroxyphenylalanine (=DOPA) on Parkinsonian akinesia. Wien Klin Wochenschr. 1961;73:787–8. - PubMed
    2. Parkinsonism Relat Disord. 1998;4:59–60. Republished in English in. - PubMed
    1. Brooks DJ. Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective. Neuropsychiatr Dis Treat. 2008;4:39–47. - PMC - PubMed
    1. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson’s disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384–6. - PubMed
    1. Frisina PG, Borod JC, Foldi NS, et al. Depression in Parkinson’s disease: Health risks, etiology, and treatment options. Neuropsychiatr Dis Treat. 2008;4:59–69. - PMC - PubMed

Publication types

LinkOut - more resources